ZBTB20 promotes ferroptosis through inhibiting TMEM109 expression in glioblastoma cells

Dang Q, Sun Z, Wang Y, Wang L, Liu Z and Han X: Ferroptosis: A double-edged sword mediating immune tolerance of cancer. Cell Death Dis. 13:9252022. View Article : Google Scholar : PubMed/NCBI

Tang D, Chen X, Kang R and Kroemer G: Ferroptosis: Molecular mechanisms and health implications. Cell Res. 31:107–125. 2021. View Article : Google Scholar :

Park E and Chung SW: ROS-mediated autophagy increases intracellular iron levels and ferroptosis by ferritin and transferrin receptor regulation. Cell Death Dis. 10:8222019. View Article : Google Scholar : PubMed/NCBI

Wang HH, Fan SQ, Zhan YT, Peng SP and Wang WY: Suppression of the SLC7A11/glutathione axis causes ferroptosis and apoptosis and alters the mitogen-activated protein kinase pathway in nasopharyngeal carcinoma. Int J Biol Macromol. 254:1279762024. View Article : Google Scholar

Bersuker K, Hendricks JM, Li Z, Magtanong L, Ford B, Tang PH, Roberts MA, Tong B, Maimone TJ, Zoncu R, et al: The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis. Nature. 575:688–692. 2019. View Article : Google Scholar : PubMed/NCBI

Su L, Zhang J, Gomez H, Kellum JA and Peng Z: Mitochondria ROS and mitophagy in acute kidney injury. Autophagy. 19:401–414. 2023. View Article : Google Scholar :

Mou Y, Wang J, Wu J, He D, Zhang C, Duan C and Li B: Ferroptosis, a new form of cell death: Opportunities and challenges in cancer. J Hematol Oncol. 12:342019. View Article : Google Scholar : PubMed/NCBI

Zhou C, Yu T, Zhu R, Lu J, Ouyang X, Zhang Z, Chen Q, Li J, Cui J, Jiang F, et al: Timosaponin AIII promotes non-small-cell lung cancer ferroptosis through targeting and facilitating HSP90 mediated GPX4 ubiquitination and degradation. Int J Biol Sci. 19:1471–1489. 2023. View Article : Google Scholar : PubMed/NCBI

Obrador E, Moreno-Murciano P, Oriol-Caballo M, López-Blanch R, Pineda B, Gutiérrez-Arroyo JL, Loras A, Gonzalez-Bonet LG, Martinez-Cadenas C, Estrela JM and Marqués-Torrejón MÁ: Glioblastoma therapy: Past, present and future. Int J Mol Sci. 25:25292024. View Article : Google Scholar : PubMed/NCBI

Zhang C, Liu X, Jin S, Chen Y and Guo R: Ferroptosis in cancer therapy: A novel approach to reversing drug resistance. Mol Cancer. 21:472022. View Article : Google Scholar : PubMed/NCBI

Zhou Q, Meng Y, Li D, Yao L, Le J, Liu Y, Sun Y, Zeng F, Chen X and Deng G: Ferroptosis in cancer: From molecular mechanisms to therapeutic strategies. Signal Transduct Target Ther. 9:552024. View Article : Google Scholar : PubMed/NCBI

Khan AB, Lee S, Harmanci AS, Patel R, Latha K, Yang Y, Marisetty A, Lee HK, Heimberger AB, Fuller GN, et al: CXCR4 expression is associated with proneural-to-mesenchymal transition in glioblastoma. Int J Cancer. 152:713–724. 2023. View Article : Google Scholar :

Ostrom QT, Bauchet L, Davis FG, Deltour I, Fisher JL, Langer CE, Pekmezci M, Schwartzbaum JA, Turner MC, Walsh KM, et al: The epidemiology of glioma in adults: A 'state of the science' review. Neuro Oncol. 16:896–913. 2014. View Article : Google Scholar : PubMed/NCBI

Khan F, Pang L, Dunterman M, Lesniak MS, Heimberger AB and Chen P: Macrophages and microglia in glioblastoma: Heterogeneity, plasticity, and therapy. J Clin Invest. 133:e1634462023. View Article : Google Scholar : PubMed/NCBI

Liu T, Zhu C, Chen X, Guan G, Zou C, Shen S, Wu J, Wang Y, Lin Z, Chen L, et al: Ferroptosis, as the most enriched programmed cell death process in glioma, induces immunosuppression and immunotherapy resistance. Neuro Oncol. 24:1113–1125. 2022. View Article : Google Scholar : PubMed/NCBI

Yadav N, Xiao A, Zhong Q, Kumar P, Konduru G, Hart W, Lazzara M and Purow B: Synergistic activity of simvastatin and irinotecan chemotherapy against glioblastoma converges on TGF-β signaling. J Neurooncol. 174:621–633. 2025. View Article : Google Scholar : PubMed/NCBI

Xing Z, Wei X, Fan Q, Zhao D, He J and Cheng J: Cryptotanshinone promotes ferroptosis in glioblastoma via KEAP1/NRF2/HMOX1 signaling pathway. Biochem Biophys Res Commun. 768:1519592025. View Article : Google Scholar : PubMed/NCBI

Nedaeinia R, Dianat-Moghadam H, Movahednasab M, Khosroabadi Z, Keshavarz M, Amoozgar Z and Salehi R: Therapeutic and prognostic values of ferroptosis signature in glioblastoma. Int Immunopharmacol. 155:1145972025. View Article : Google Scholar : PubMed/NCBI

Sun J, Xue B, Sun T, Xu X, Zhang D, Shan Z, Wang Y and Chen B: PTBP1 acts as a tumor suppressor in glioma by promoting HMOX1-dependent ferroptosis. Biochem Pharmacol. 239:1170412025. View Article : Google Scholar : PubMed/NCBI

Su IC, Su YK, Setiawan SA, Yadav VK, Fong IH, Yeh CT, Lin CM and Liu HW: NADPH oxidase subunit CYBB confers chemotherapy and ferroptosis resistance in mesenchymal glioblastoma via Nrf2/SOD2 modulation. Int J Mol Sci. 24:77062023. View Article : Google Scholar : PubMed/NCBI

Xu H, Wu Z, Tang J, Gan Y, Li J, Yu Y, Chen Y, Sui R, Liu J, Zhang Y and Piao H: Ginsenoside F2-modified liposomes delivering FTY720 enhance glioblastoma targeting and antitumor activity via ferroptosis. Phytomedicine. 144:1569172025. View Article : Google Scholar : PubMed/NCBI

Zheng H, Guo Z, Chen F, Zhong Q, Hu Y, Du C, Wang H, Wei P, Huang W, Wang D, et al: Engineering charge density in s-block potassium single-atom nanozyme for amplified ferroptosis in glioblastoma therapy. Mater Today Bio. 32:1018892025. View Article : Google Scholar : PubMed/NCBI

Qiao Y, Liu M, Zhang Y, Ni F, Yu L, Chen Z, Dai X and Wang X: Gambogic acid-iron nanozymes as effective carriers for enhanced chemotherapy by inducing excessive autophagy and oxidative stress. J Nanobiotechnology. 23:4352025. View Article : Google Scholar : PubMed/NCBI

Yin N, Wang B, Wang Y, Tian L, Han S, Zheng B, Feng F, Song S and Zhang H: A metal-phenolic network nanoresensitizer overcoming glioblastoma drug resistance through the metabolic adaptive strategy and targeting drug-tolerant cells. Nano Lett. 25:9570–9580. 2025. View Article : Google Scholar : PubMed/NCBI

Zhang H, Feng K, Han M, Shi Y, Zhang Y, Wu J, Yang W, Wang X, Di L and Wang R: Homologous magnetic targeted immune vesicles for amplifying immunotherapy via ferroptosis activation augmented photodynamic therapy against glioblastoma. J Control Release. 383:1138162025. View Article : Google Scholar : PubMed/NCBI

Jiang Y, Zhao J, Li R, Liu Y, Zhou L, Wang C, Lv C, Gao L and Cui D: CircLRFN5 inhibits the progression of glioblastoma via PRRX2/GCH1 mediated ferroptosis. J Exp Clin Cancer Res. 41:3072022. View Article : Google Scholar : PubMed/NCBI

Janczarek M: The Ros/MucR zinc-finger protein family in bacteria: Structure and functions. Int J Mol Sci. 23:155362022. View Article : Google Scholar : PubMed/NCBI

Li F, Du M, Yang Y, Wang Z, Zhang H, Wang X and Li Q: Zinc finger and BTB domain-containing protein 20 aggravates angiotensin II-induced cardiac remodeling via the EGFR-AKT pathway. J Mol Med (Berl). 100:427–438. 2022. View Article : Google Scholar

Zhang W, Mi J, Li N, Sui L, Wan T, Zhang J, Chen T and Cao X: Identification and characterization of DPZF, a novel human BTB/POZ zinc finger protein sharing homology to BCL-6. Biochem Biophys Res Commun. 282:1067–1073. 2001. View Article : Google Scholar : PubMed/NCBI

Zhang Y, Zhou X, Zhang M, Cheng L, Zhang Y and Wang X: ZBTB20 promotes cell migration and invasion of gastric cancer by inhibiting IκBα to induce NF-κB activation. Artif Cells Nanomed Biotechnol. 47:3862–3872. 2019. View Article : Google Scholar : PubMed/NCBI

Juven A, Nambot S, Piton A, Jean-Marçais N, Masurel A, Callier P, Marle N, Mosca-Boidron AL, Kuentz P, Philippe C, et al: Primrose syndrome: A phenotypic comparison of patients with a ZBTB20 missense variant versus a 3q13.31 microdeletion including ZBTB20. Eur J Hum Genet. 28:1044–1055. 2020. View Article : Google Scholar : PubMed/NCBI

Han Q, Yan X, Ye Y, Han L, Ma X, Wang T, Cao D and Zhang WJ: ZBTB20 regulates prolactin expression and lactotrope function in adult mice. Endocrinology. 163:bqac1812022. View Article : Google Scholar : PubMed/NCBI

Cao D, Ma X, Cai J, Luan J, Liu AJ, Yang R, Cao Y, Zhu X, Zhang H, Chen YX, et al: ZBTB20 is required for anterior pituitary development and lactotrope specification. Nat Commun. 7:111212016. View Article : Google Scholar : PubMed/NCBI

To JC, Chiu AP, Tschida BR, Lo LH, Chiu CH, Li XX, Kuka TP, Linden MA, Amin K, Chan WC, et al: ZBTB20 regulates WNT/CTNNB1 signalling pathway by suppressing PPARG during hepatocellular carcinoma tumourigenesis. JHEP Rep. 3:1002232020. View Article : Google Scholar

Kan H, Huang Y, Li X, Liu D, Chen J and Shu M: Zinc finger protein ZBTB20 is an independent prognostic marker and promotes tumor growth of human hepatocellular carcinoma by repressing FoxO1. Oncotarget. 7:14336–14349. 2016. View Article : Google Scholar : PubMed/NCBI

Nagao M, Ogata T, Sawada Y and Gotoh Y: Zbtb20 promotes astrocytogenesis during neocortical development. Nat Commun. 7:111022016. View Article : Google Scholar : PubMed/NCBI

Li F, Yang Y, Xue C, Tan M, Xu L, Gao J, Xu L, Zong J and Qian W: Zinc finger protein ZBTB20 protects against cardiac remodelling post-myocardial infarction via ROS-TNFα/ASK1/JNK pathway regulation. J Cell Mol Med. 24:13383–13396. 2020. View Article : Google Scholar : PubMed/NCBI

Wang B, Wang Y, Zhang J, Hu C, Jiang J, Li Y and Peng Z: ROS-induced lipid peroxidation modulates cell death outcome: Mechanisms behind apoptosis, autophagy, and ferroptosis. Arch Toxicol. 97:1439–1451. 2023. View Article : Google Scholar : PubMed/NCBI

Zhang S, Liu Q, Chang M, Pan Y, Yahaya BH, Liu Y and Lin J: Chemotherapy impairs ovarian function through excessive ROS-induced ferroptosis. Cell Death Dis. 14:3402023. View Article : Google Scholar : PubMed/NCBI

Tirincsi A, O'Keefe S, Nguyen D, Sicking M, Dudek J, Förster F, Jung M, Hadzibeganovic D, Helms V, High S, et al: Proteomics identifies substrates and a novel component in hSnd2-dependent ER protein targeting. Cells. 11:29252022. View Article : Google Scholar : PubMed/NCBI

Takeshima H, Venturi E and Sitsapesan R: New and notable ion-channels in the sarcoplasmic/endoplasmic reticulum: Do they support the process of intracellular Ca²⁺ release? J Physiol. 593:3241–3251. 2015. View Article : Google Scholar : PubMed/NCBI

Nishi M, Komazaki S, Iino M, Kangawa K and Takeshima H: Mitsugumin23, a novel transmembrane protein on endoplasmic reticulum and nuclear membranes. FEBS Lett. 432:191–196. 1998. View Article : Google Scholar : PubMed/NCBI

Venturi E, Mio K, Nishi M, Ogura T, Moriya T, Pitt SJ, Okuda K, Kakizawa S, Sitsapesan R, Sato C and Takeshima H: Mitsugumin 23 forms a massive bowl-shaped assembly and cation-conducting channel. Biochemistry. 50:2623–2632. 2011. View Article : Google Scholar : PubMed/NCBI

Yamashita A, Taniwaki T, Kaikoi Y and Yamazaki T: Protective role of the endoplasmic reticulum protein mitsugumin23 against ultraviolet C-induced cell death. FEBS Lett. 587:1299–1303. 2013. View Article : Google Scholar : PubMed/NCBI

Liang D, Feng Y, Zandkarimi F, Wang H, Zhang Z, Kim J, Cai Y, Gu W, Stockwell BR and Jiang X: Ferroptosis surveillance independent of GPX4 and differentially regulated by sex hormones. Cell. 186:2748–2764.e22. 2023. View Article : Google Scholar : PubMed/NCBI

Chen X, Yu C, Kang R, Kroemer G and Tang D: Cellular degradation systems in ferroptosis. Cell Death Differ. 28:1135–1148. 2021. View Article : Google Scholar : PubMed/NCBI

Duan P, Li B, Zhou Y, Cao H, Chen S and Xing Y: ZBTB20 suppresses tumor growth in glioblastoma through activating the TET1/FAS/caspase-3 pathway. Oncol Lett. 28:3582024. View Article : Google Scholar

Watanabe D, Nishi M, Liu F, Bian Y and Takeshima H: Ca²⁺ storage function is altered in the sarcoplasmic reticulum of skeletal muscle lacking mitsugumin 23. Am J Physiol Cell Physiol. 326:C795–C809. 2024. View Article : Google Scholar

Wang S, Li W, Zhang P, Wang Z, Ma X, Liu C, Vasilev K, Zhang L, Zhou X, Liu L, et al: Mechanical overloading induces GPX4-regulated chondrocyte ferroptosis in osteoarthritis via Piezo1 channel facilitated calcium influx. J Adv Res. 41:63–75. 2022. View Article : Google Scholar : PubMed/NCBI

Li D, Wang Y, Dong C, Chen T, Dong A, Ren J, Li W, Shu G, Yang J, Shen W, et al: CST1 inhibits ferroptosis and promotes gastric cancer metastasis by regulating GPX4 protein stability via OTUB1. Oncogene. 42:83–98. 2023. View Article : Google Scholar :

Sun Q, Lu H, Yuan F, Zhao Q, Wei Y, Wang R, Chen Q and Liu B: SLC10A3 regulates ferroptosis of glioblastoma through the STAT3/GPX4 pathway. Sci Rep. 15:212592025. View Article : Google Scholar : PubMed/NCBI

Miao Z, Tian W, Ye Y, Gu W, Bao Z, Xu L, Sun G, Li C, Tu Y, Chao H, et al: Hsp90 induces Acsl4-dependent glioma ferroptosis via dephosphorylating Ser637 at Drp1. Cell Death Dis. 13:5482022. View Article : Google Scholar : PubMed/NCBI

Wan RJ, Peng W, Xia QX, Zhou HH and Mao XY: Ferroptosis-related gene signature predicts prognosis and immunotherapy in glioma. CNS Neurosci Ther. 27:973–986. 2021. View Article : Google Scholar : PubMed/NCBI

Li S, Lu Z, Sun R, Guo S, Gao F, Cao B and Aa J: The role of SLC7A11 in cancer: Friend or foe? Cancers (Basel). 14:30592022. View Article : Google Scholar : PubMed/NCBI

Lin Y, Dong Y, Liu W, Fan X and Sun Y: Pan-cancer analyses confirmed the ferroptosis-related gene SLC7A11 as a prognostic biomarker for cancer. Int J Gen Med. 15:2501–2513. 2022. View Article : Google Scholar : PubMed/NCBI

Chen Y, Mi Y, Zhang X, Ma Q, Song Y, Zhang L, Wang D, Xing J, Hou B, Li H, et al: Dihydroartemisinin-induced unfolded protein response feedback attenuates ferroptosis via PERK/ATF4/HSPA5 pathway in glioma cells. J Exp Clin Cancer Res. 38:4022019. View Article : Google Scholar : PubMed/NCBI

Chen X, Wang Z, Li C, Zhang Z, Lu S, Wang X, Liang Q, Zhu X, Pan C, Wang Q, et al: SIRT1 activated by AROS sensitizes glioma cells to ferroptosis via induction of NAD+ depletion-dependent activation of ATF3. Redox Biol. 69:1030302024. View Article : Google Scholar : PubMed/NCBI

Koppula P, Zhuang L and Gan B: Cystine transporter SLC7A11/xCT in cancer: Ferroptosis, nutrient dependency, and cancer therapy. Protein Cell. 12:599–620. 2021. View Article : Google Scholar :

Ye Y, Chen A, Li L, Liang Q, Wang S, Dong Q, Fu M, Lan Z, Li Y, Liu X, et al: Repression of the antiporter SLC7A11/glutathione/glutathione peroxidase 4 axis drives ferroptosis of vascular smooth muscle cells to facilitate vascular calcification. Kidney Int. 102:1259–1275. 2022. View Article : Google Scholar : PubMed/NCBI

Wang L, Liu Y, Du T, Yang H, Lei L, Guo M, Ding HF, Zhang J, Wang H, Chen X and Yan C: ATF3 promotes erastin-induced ferroptosis by suppressing system Xc. Cell Death Differ. 27:662–675. 2020. View Article : Google Scholar

Liu Y, Lu S, Wu LL, Yang L, Yang L and Wang J: The diversified role of mitochondria in ferroptosis in cancer. Cell Death Dis. 14:5192023. View Article : Google Scholar : PubMed/NCBI

Liu S, Wu W, Chen Q, Zheng Z, Jiang X, Xue Y and Lin D: TXNRD1: A key regulator involved in the ferroptosis of CML cells induced by cysteine depletion in vitro. Oxid Med Cell Longev. 2021:76745652021. View Article : Google Scholar : PubMed/NCBI

Wang X, Wang Y, Huang D, Shi S, Pei C, Wu Y, Shen Z, Wang F and Wang Z: Astragaloside IV regulates the ferroptosis signaling pathway via the Nrf2/SLC7A11/GPX4 axis to inhibit PM2.5-mediated lung injury in mice. Int Immunopharmacol. 112:1091862022. View Article : Google Scholar : PubMed/NCBI

Campos J, Gleitze S, Hidalgo C and Núñez MT: IP₃R-mediated calcium release promotes ferroptotic death in SH-SY5Y neuroblastoma cells. Antioxidants (Basel). 13:1962024. View Article : Google Scholar

Xin S, Mueller C, Pfeiffer S, Kraft VAN, Merl-Pham J, Bao X, Feederle R, Jin X, Hauck SM, Schmitt-Kopplin P and Schick JA: MS4A15 drives ferroptosis resistance through calcium-restricted lipid remodeling. Cell Death Differ. 29:670–686. 2022. View Article : Google Scholar :

Gleitze S, Ramírez OA, Vega-Vásquez I, Yan J, Lobos P, Bading H, Núñez MT, Paula-Lima A and Hidalgo C: Ryanodine receptor mediated calcium release contributes to ferroptosis induced in primary hippocampal neurons by GPX4 inhibition. Antioxidants (Basel). 12:7052023. View Article : Google Scholar : PubMed/NCBI